{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:06:45Z","timestamp":1648505205200},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00347-013-2983-y","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T04:38:43Z","timestamp":1407731923000},"page":"722-726","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aktuelle Empfehlungen zur Neuritis nervi optici"],"prefix":"10.1007","volume":"111","author":[{"given":"F.","family":"Beisse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Beisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Lagr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"R\u00fcther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schiefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,13]]},"reference":[{"key":"2983_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326:581\u2013588","journal-title":"N Engl J Med"},{"key":"2983_CR2","unstructured":"Berufsverband der Augen\u00e4rzte Deutschlands e. V, Deutsche Ophthalmologische Gesellschaft (2007) Leitlinie Nr. 30 \u2013 Neuritis nervi optici. http:\/\/www.dog.org\/wp-content\/uploads\/2009\/09\/Leitlinie-Nr.-30-Neuritis-nervi-optici.pdf"},{"key":"2983_CR3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"Costello","year":"2006","unstructured":"Costello F, Coupland S, Hodge W et al (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59:963\u2013969","journal-title":"Ann Neurol"},{"key":"2983_CR4","unstructured":"DGN, KKNMS (2012) DGN\/KKNMS-Leitlinie zur Diagnose und Therapie der Multiplen Sklerose. http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/030-050.html"},{"key":"2983_CR5","first-page":"CD001430","volume":"4","author":"Gal","year":"2012","unstructured":"Gal RL, Vedula SS, Beck R (2012) Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev 4:CD001430","journal-title":"Cochrane Database Syst Rev"},{"key":"2983_CR6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/jnnp.74.8.1139","volume":"74","author":"Hickman","year":"2003","unstructured":"Hickman SJ, Kapoor R, Jones SJ et al (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psych 74:1139\u20131141","journal-title":"J Neurol Neurosurg Psych"},{"key":"2983_CR7","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"Jarius","year":"2008","unstructured":"Jarius S, Aboul-Enein F, Waters P et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131:3072\u20133080","journal-title":"Brain"},{"key":"2983_CR8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.50.1.230","volume":"50","author":"Kapoor","year":"1998","unstructured":"Kapoor R, Miller DH, Jones SJ et al (1998) Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 50:230\u2013237","journal-title":"Neurology"},{"key":"2983_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"Keegan","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL et al (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143\u2013146","journal-title":"Neurology"},{"key":"2983_CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","volume":"111","author":"Keltner","year":"1993","unstructured":"Keltner JL, Johnson CA, Spurr JO et al (1993) Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 111:231\u2013234","journal-title":"Arch Ophthalmol"},{"key":"2983_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archopht.1960.00950020749001","volume":"63","author":"Kennedy","year":"1960","unstructured":"Kennedy C, Carroll FD (1960) Optic neuritis in children. Arch Ophthalmol 63:747\u2013755","journal-title":"Arch Ophthalmol"},{"key":"2983_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","volume":"126","author":"Kidd","year":"2003","unstructured":"Kidd D, Burton B, Plant GT et al (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126:276\u2013284","journal-title":"Brain"},{"key":"2983_CR13","first-page":"15","volume":"2","author":"Kurne","year":"2010","unstructured":"Kurne A, Karabudak R, Yalcin-Cakmakli G (2010) Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients. Eye Brain 2:15\u201320","journal-title":"Eye Brain"},{"key":"2983_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/brain\/110.2.405","volume":"110","author":"Lightman","year":"1987","unstructured":"Lightman S, McDonald WI, Bird AC et al (1987) Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 110:405\u2013414","journal-title":"Brain"},{"key":"2983_CR15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s001150050452","volume":"70","author":"Multiple-Sklerose-Konsensus-Gruppe","year":"1999","unstructured":"Multiple-Sklerose-Konsensus-Gruppe (1999) Immunmodulatorische Stufentherapie der multiplen Sklerose. Nervenarzt 70:371\u2013386","journal-title":"Nervenarzt"},{"key":"2983_CR16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00417-007-0722-2","volume":"246","author":"Nevalainen","year":"2008","unstructured":"Nevalainen J, Krapp E, Paetzold J et al (2008) Visual field defects in acute optic neuritis \u2013 distribution of different types of defect pattern, assessed with threshold-related supraliminal perimetry, ensuring high spatial resolution. Graefes Arch Clin Exp Ophthalmol 246:599\u2013607","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2983_CR17","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","volume":"109","author":"Optic","year":"1991","unstructured":"Optic Neuritis Study Group (1991) The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 109:1673\u20131678","journal-title":"Arch Ophthalmol"},{"key":"2983_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"Toosy","year":"2014","unstructured":"Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83\u201399","journal-title":"Lancet Neurol"},{"key":"2983_CR19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","volume":"119","author":"Walter","year":"2012","unstructured":"Walter SD, Ishikawa H, Galetta KM et al (2012) Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 119:1250\u20131257","journal-title":"Ophthalmology"},{"key":"2983_CR20","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/brain\/114.6.2437","volume":"114","author":"Youl","year":"1991","unstructured":"Youl BD, Turano G, Miller DH et al (1991) The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114:2437\u20132450","journal-title":"Brain"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2983-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-013-2983-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-2983-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:51:54Z","timestamp":1559037114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-013-2983-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2983"],"URL":"https:\/\/doi.org\/10.1007\/s00347-013-2983-y","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}